Nuclear Molecular Imaging of Disease Burden and Response to Treatment for Cardiac Amyloidosis
Cardiac amyloidosis (CA) is a heterogeneous group of diseases in which extracellular insoluble amyloid proteins are deposited in specific organs and tissues locally or systemically, thereby interfering with physiological function. Transthyretin protein (TTR) and light chain (AL) amyloidosis are the...
Main Authors: | Min Zhao, Raffaella Calabretta, Josef Yu, Patrick Binder, Shuo Hu, Marcus Hacker, Xiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/10/1395 |
Similar Items
-
Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis
by: Ilknur Ak Sivrikoz, et al.
Published: (2020-07-01) -
Advanced Imaging in Cardiac Amyloidosis
by: Dominik Waldmeier, et al.
Published: (2022-04-01) -
Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
by: Alain Manrique, et al.
Published: (2019-12-01) -
Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021
by: Weijia Li, et al.
Published: (2021-05-01) -
Semi-Quantification of Myocardial Uptake of Bone-Seeking Agents in Suspected Cardiac Amyloidosis
by: Cristina Campi, et al.
Published: (2023-04-01)